9 research outputs found
To Assess the Association between Glucose Metabolism and Ectopic Lipid Content in Different Clinical Classifications of PCOS - Fig 3
<p>Bee swarm plot of ectopic lipids in different subgroups: controls (CONT), females with PCOS classified by NIH 1999 criteria (PCOS-NIH) as well as females with PCOS additionally classified by the Rotterdam 2003 criteria (PCOS-ROT): A: Hepatocellular lipids (HCL), B: intramyocellular lipids (IMCL) in soleus muscle, C: intramyocellular lipids (IMCL) in tibialis muscle. Lines indicate first, second (median) and third quartiles.</p
Sensitivity analysis excluding 10 controls with systemic contraceptive agents during the study period.
<p>Sensitivity analysis excluding 10 controls with systemic contraceptive agents during the study period.</p
Summary of missing OGTT data in PCOS and controls.
<p>Summary of missing OGTT data in PCOS and controls.</p
Basic characteristics of the study sample.
<p>Basic characteristics of the study sample.</p
Spaghetti plots of plasma glucose, insulin and C-Peptide dynamics during a 2h-oral glucose tolerance test (OGTT) in control subjects, patients with PCOS classified by NIH 1999 criteria (PCOS-NIH) as well as patients with PCOS additionally classified by the Rotterdam 2003 criteria (PCOS-ROT).
<p>Spaghetti plots of plasma glucose, insulin and C-Peptide dynamics during a 2h-oral glucose tolerance test (OGTT) in control subjects, patients with PCOS classified by NIH 1999 criteria (PCOS-NIH) as well as patients with PCOS additionally classified by the Rotterdam 2003 criteria (PCOS-ROT).</p
Comparision of glucometabolic parameters.
<p>Comparision of glucometabolic parameters.</p
Correlation map representing the amount of association of clinical and metabolic parameters with hepatic (HCL) and intramyocellular (IMCL) lipid content of females with PCOS.
<p>The magnitude of correlation is indicated by the shape of the ellipses (circle represents no correlation) and color (dark color represents higher correlation; positive = blue, negative = red).</p
Estimator of nonparametric relative effects and 95% simultaneous confidence intervals (PCOS phenotypes vs. subgroups) for HOMA-IR (homeostatic model assessment of insulin resistance); ISI-Comp (Composite index), AUC-I (area under the concentration curve of insulin) as well as Sec-Total (total insulin secretion) for PCOS subgroups and controls, respectively.
<p>A: ovulatory dysfunction + hyperandogenism + polycystic ovaries (n = 28); B: ovulatory dysfunction + hyperandrogenism (n = 7); C: ovulatory dysfunction + polycystic ovary (n = 11); D: hyperandrogenism + polycystic ovary (n = 7); cont: controls (n = 20).</p